»search site
The International Academy of Cardiology is dedicated to the advancement of global research in cardiovascular medicine through the support of scientific meetings and publications.
   Home Page
   Congresses
   Journals
   Organizations
   Books
   Research
   Guidelines
   Discussion Groups
   Webcourses
   Websites
   Job Opportunities
   Contact Us

 


 

  VALVULAR CARDIOLOGY


 Editor: Asher Kimchi, MD

 
Daptomycin may be an Alternative to Standard Therapy for Bacteremia and Endocarditis Caused by Staphylococcus aureus
Staphylococcus Aureus is a leading cause of bacteremia and endocarditis. Gentamicin plus penicillin or vancomycin is standard therapy for S. Aureus bacteremia. Vancomycin is the standard therapy for blood-stream infections attributable to methicillin-resistant S. aureus (MRSA). The standard therapy has been associated with suboptimal outcomes. Vance G. Fowler, Jr., MD, MHS, et al from Duke University Medical Center set out to establish whether daptomycin is an effective and safe treatment for S. aureus bacteremia and endocarditis. The study, published in the August 17, 2006 issue of The New England Journal of Medicine found that Daptomycin (6 mg per kilogram daily) is not inferior to standard therapy for S. aureus bacteremia and right-sided endocarditis. MOREĽ


 

 

 

 

 


 

©1998-2009 Cardiology Online, Inc. All rights reserved.
Cardiology Online is a registered trademark of Cardiology Online, Inc.
CardiologyOnline.com